Crosstalk between TGFβ and Wnt signaling pathways in the human trabecular meshwork

Hannah C. Webber, Jaclyn Y. Bermudez, Anirudh Sethi, Abbot Clark, Weiming Mao

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Primary Open Angle Glaucoma (POAG) is an irreversible, vision-threatening disease that affects millions worldwide. The principal risk factor of POAG is increased intraocular pressure (IOP) due to pathological changes in the trabecular meshwork (TM). The TGFβ signaling pathway activator TGFβ2 and the Wnt signaling pathway inhibitor secreted frizzled-related protein 1 (sFRP1) are elevated in the POAG TM. In this study, we determined whether there is a crosstalk between the TGFβ/Smad pathway and the canonical Wnt pathway using luciferase reporter assays. Lentiviral luciferase reporter vectors for studying the TGFβ/Smad pathway or the canonical Wnt pathway were transduced into primary human non-glaucomatous TM (NTM) cells. Cells were treated with or without a combination of 5 μg/ml TGFβ2 and/or 100 ng/ml Wnt3a recombinant proteins, and luciferase levels were measured using a plate reader. We found that TGFβ2 inhibited Wnt3a-induced canonical Wnt pathway activation, while Wnt3a inhibited TGFβ2-induced TGFβ/Smad pathway activation (n = 6, p < 0.05) in 3 NTM cell strains. We also found that knocking down of Smad4 or β-catenin using siRNA in HTM5 cells transfected with similar luciferase reporter plasmids abolished the inhibitory effect of TGFβ2 and/or Wnt3a on the other pathway (n = 6). Our results suggest the existence of a cross-inhibition between the TGFβ/Smad and canonical Wnt pathways in the TM, and this cross-inhibition may be mediated by Smad4 and β-catenin.

Original languageEnglish
Pages (from-to)97-102
Number of pages6
JournalExperimental eye research
Volume148
DOIs
StatePublished - 1 Jul 2016

Fingerprint

Trabecular Meshwork
Wnt Signaling Pathway
Luciferases
Catenins
Wnt3A Protein
Intraocular Pressure
Recombinant Proteins
Small Interfering RNA
Plasmids
Primary Open Angle Glaucoma

Keywords

  • Crosstalk
  • Glaucoma
  • Smad4
  • TGFβ signaling
  • Trabecular meshwork
  • Wnt signaling
  • β-catenin

Cite this

Webber, Hannah C. ; Bermudez, Jaclyn Y. ; Sethi, Anirudh ; Clark, Abbot ; Mao, Weiming. / Crosstalk between TGFβ and Wnt signaling pathways in the human trabecular meshwork. In: Experimental eye research. 2016 ; Vol. 148. pp. 97-102.
@article{3a0c3745e2e24ce38c33e6b28fd22b80,
title = "Crosstalk between TGFβ and Wnt signaling pathways in the human trabecular meshwork",
abstract = "Primary Open Angle Glaucoma (POAG) is an irreversible, vision-threatening disease that affects millions worldwide. The principal risk factor of POAG is increased intraocular pressure (IOP) due to pathological changes in the trabecular meshwork (TM). The TGFβ signaling pathway activator TGFβ2 and the Wnt signaling pathway inhibitor secreted frizzled-related protein 1 (sFRP1) are elevated in the POAG TM. In this study, we determined whether there is a crosstalk between the TGFβ/Smad pathway and the canonical Wnt pathway using luciferase reporter assays. Lentiviral luciferase reporter vectors for studying the TGFβ/Smad pathway or the canonical Wnt pathway were transduced into primary human non-glaucomatous TM (NTM) cells. Cells were treated with or without a combination of 5 μg/ml TGFβ2 and/or 100 ng/ml Wnt3a recombinant proteins, and luciferase levels were measured using a plate reader. We found that TGFβ2 inhibited Wnt3a-induced canonical Wnt pathway activation, while Wnt3a inhibited TGFβ2-induced TGFβ/Smad pathway activation (n = 6, p < 0.05) in 3 NTM cell strains. We also found that knocking down of Smad4 or β-catenin using siRNA in HTM5 cells transfected with similar luciferase reporter plasmids abolished the inhibitory effect of TGFβ2 and/or Wnt3a on the other pathway (n = 6). Our results suggest the existence of a cross-inhibition between the TGFβ/Smad and canonical Wnt pathways in the TM, and this cross-inhibition may be mediated by Smad4 and β-catenin.",
keywords = "Crosstalk, Glaucoma, Smad4, TGFβ signaling, Trabecular meshwork, Wnt signaling, β-catenin",
author = "Webber, {Hannah C.} and Bermudez, {Jaclyn Y.} and Anirudh Sethi and Abbot Clark and Weiming Mao",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/j.exer.2016.04.007",
language = "English",
volume = "148",
pages = "97--102",
journal = "Experimental Eye Research",
issn = "0014-4835",
publisher = "Academic Press Inc.",

}

Crosstalk between TGFβ and Wnt signaling pathways in the human trabecular meshwork. / Webber, Hannah C.; Bermudez, Jaclyn Y.; Sethi, Anirudh; Clark, Abbot; Mao, Weiming.

In: Experimental eye research, Vol. 148, 01.07.2016, p. 97-102.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Crosstalk between TGFβ and Wnt signaling pathways in the human trabecular meshwork

AU - Webber, Hannah C.

AU - Bermudez, Jaclyn Y.

AU - Sethi, Anirudh

AU - Clark, Abbot

AU - Mao, Weiming

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Primary Open Angle Glaucoma (POAG) is an irreversible, vision-threatening disease that affects millions worldwide. The principal risk factor of POAG is increased intraocular pressure (IOP) due to pathological changes in the trabecular meshwork (TM). The TGFβ signaling pathway activator TGFβ2 and the Wnt signaling pathway inhibitor secreted frizzled-related protein 1 (sFRP1) are elevated in the POAG TM. In this study, we determined whether there is a crosstalk between the TGFβ/Smad pathway and the canonical Wnt pathway using luciferase reporter assays. Lentiviral luciferase reporter vectors for studying the TGFβ/Smad pathway or the canonical Wnt pathway were transduced into primary human non-glaucomatous TM (NTM) cells. Cells were treated with or without a combination of 5 μg/ml TGFβ2 and/or 100 ng/ml Wnt3a recombinant proteins, and luciferase levels were measured using a plate reader. We found that TGFβ2 inhibited Wnt3a-induced canonical Wnt pathway activation, while Wnt3a inhibited TGFβ2-induced TGFβ/Smad pathway activation (n = 6, p < 0.05) in 3 NTM cell strains. We also found that knocking down of Smad4 or β-catenin using siRNA in HTM5 cells transfected with similar luciferase reporter plasmids abolished the inhibitory effect of TGFβ2 and/or Wnt3a on the other pathway (n = 6). Our results suggest the existence of a cross-inhibition between the TGFβ/Smad and canonical Wnt pathways in the TM, and this cross-inhibition may be mediated by Smad4 and β-catenin.

AB - Primary Open Angle Glaucoma (POAG) is an irreversible, vision-threatening disease that affects millions worldwide. The principal risk factor of POAG is increased intraocular pressure (IOP) due to pathological changes in the trabecular meshwork (TM). The TGFβ signaling pathway activator TGFβ2 and the Wnt signaling pathway inhibitor secreted frizzled-related protein 1 (sFRP1) are elevated in the POAG TM. In this study, we determined whether there is a crosstalk between the TGFβ/Smad pathway and the canonical Wnt pathway using luciferase reporter assays. Lentiviral luciferase reporter vectors for studying the TGFβ/Smad pathway or the canonical Wnt pathway were transduced into primary human non-glaucomatous TM (NTM) cells. Cells were treated with or without a combination of 5 μg/ml TGFβ2 and/or 100 ng/ml Wnt3a recombinant proteins, and luciferase levels were measured using a plate reader. We found that TGFβ2 inhibited Wnt3a-induced canonical Wnt pathway activation, while Wnt3a inhibited TGFβ2-induced TGFβ/Smad pathway activation (n = 6, p < 0.05) in 3 NTM cell strains. We also found that knocking down of Smad4 or β-catenin using siRNA in HTM5 cells transfected with similar luciferase reporter plasmids abolished the inhibitory effect of TGFβ2 and/or Wnt3a on the other pathway (n = 6). Our results suggest the existence of a cross-inhibition between the TGFβ/Smad and canonical Wnt pathways in the TM, and this cross-inhibition may be mediated by Smad4 and β-catenin.

KW - Crosstalk

KW - Glaucoma

KW - Smad4

KW - TGFβ signaling

KW - Trabecular meshwork

KW - Wnt signaling

KW - β-catenin

UR - http://www.scopus.com/inward/record.url?scp=84974604445&partnerID=8YFLogxK

U2 - 10.1016/j.exer.2016.04.007

DO - 10.1016/j.exer.2016.04.007

M3 - Article

C2 - 27091054

AN - SCOPUS:84974604445

VL - 148

SP - 97

EP - 102

JO - Experimental Eye Research

JF - Experimental Eye Research

SN - 0014-4835

ER -